← Leaderboards
Zhaoxia Qu
University Of Pittsburgh At Pittsburgh
$3,026,704
Attributed
$4,854,965
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,854,965 · 4
By mechanism
R01$4,486,520 · 3
R21$368,445 · 1
Top collaborators
- Gutian Xiao9 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Donald B Defranco$10,683,038
- Candace S Johnson$18,922,226
- Anuradha Ray$26,369,891
- Jeremy N Rich$24,023,429
- Thomas Edward Smithgall$26,440,514
Others in their field
Top investigators on “Nf-Kappa B”
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Rebecca Fry · Univ Of North Carolina Chapel Hill$15,688,258
- Michael Karin · University Of California, San Diego$14,171,420
- Cun-Yu Wang · University Of California Los Angeles$13,411,656
- T Michael O'Shea · Wake Forest University Health Sciences$13,401,435
- Dennis Carson · University Of California, San Diego$12,734,498
Research focus
Nf-Kappa BPathogenesisInnovationMolecularSignal TransductionCellsProteinsTumor Suppressor ProteinsPreventIn VivoLim DomainRepressionPhysiologicalPlayIn VitroLungInflammatoryLung InfectionsSingle-Cell Rna SequencingPhysiologyCessation Of LifeMouse ModelMalignant Neoplasm Of LungKnock-In Mouse
Grant awards (12)
The NF-kappaB modulator PDLIM2 as an intrinsic checkpoint of alveolar macrophages critical for lung innate immunity, inflammation and diseases$829,998
R01 · FY2025 · HL · contact PI
Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases$478,500
R01 · FY2025 · GM · contact PI
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis$389,761
R01 · FY2025 · CA · contact PI
Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases$478,500
R01 · FY2024 · GM · contact PI
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis$370,274
R01 · FY2024 · CA · contact PI
Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases$478,500
R01 · FY2023 · GM
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis$381,967
R01 · FY2023 · CA
Administrative Supplement: Dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases$210,759
R01 · FY2023 · GM
Structural and molecular dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases$478,500
R01 · FY2022 · GM
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis$389,761
R01 · FY2022 · CA
Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV$200,970
R21 · FY2016 · CA · contact PI
Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV$167,475
R21 · FY2015 · CA · contact PI